Business Description
Savara Inc. is a US-based medical research company working to develop treatments for uncommon lung conditions. Its primary drug in development, molgramostim, is an inhaled therapy currently in late-stage clinical trials for a rare disease in which a harmful substance builds up in the lungs, making it difficult to breathe. Founded in 2007 and based in Langhorne, Pennsylvania, the company has yet to bring a product to market.
